Security
Idera Pharmaceuticals, Inc. Warrants exp 5/7/2018 · IDRAW
IDRAWOTCWarrantHistorical · closed May 8, 2018CIK 861838Updated Nov 16, 2026
Name history
IDERA PHARMACEUTICALS, INC. · through Jan 13, 2023HYBRIDON INC · through Sep 2, 2005
IDRAW price & chart
Historical security
This listing closed May 8, 2018. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 101,107,000Source | 34,864,000Source | 42,399,000Source | 47,489,000Source |
| Property, Plant and Equipment, NetUSD | 7,000Source | 22,000Source | 44,000Source | 97,000Source |
| GoodwillUSD | 11,100,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 71,600,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,044,000Source | 32,545,000Source | 33,229,000Source | 40,019,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 4,208,000Source | — | — | — |
| Assets, CurrentUSD | 17,863,000Source | 34,038,000Source | 41,355,000Source | 46,268,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,611,000Source | 1,493,000Source | 3,627,000Source | 3,475,000Source |
| Operating Lease, Right-of-Use AssetUSD | 537,000Source | 734,000Source | 930,000Source | 1,054,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 62,173,000Source | 5,411,000Source | 133,571,000Source | 58,657,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 4,000Source | 53,000Source | 38,000Source | 30,000Source |
| Additional Paid in CapitalUSD | 770,663,000Source | 764,861,000Source | 742,342,000Source | 709,692,000Source |
| Retained Earnings (Accumulated Deficit)USD | -758,821,000Source | -735,461,000Source | -833,552,000Source | -720,890,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -21,000Source | — | — | — |
| Stockholders' Equity Attributable to ParentUSD | 11,826,000Source | 29,453,000Source | -91,172,000Source | -11,168,000Source |
| Liabilities and EquityUSD | 101,107,000Source | 34,864,000Source | 42,399,000Source | 47,489,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 21,423,000Source | 4,862,000Source | 7,027,000Source | 54,517,000Source |
| Operating Lease, Liability, CurrentUSD | 234,000Source | 209,000Source | 191,000Source | 163,000Source |
| Accounts Payable, CurrentUSD | 5,200,000Source | 565,000Source | 329,000Source | 457,000Source |
| Operating Lease, Liability, NoncurrentUSD | 326,000Source | 549,000Source | 758,000Source | 899,000Source |
| Deferred Income Tax Liabilities, NetUSD | 3,283,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 22,000Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,911,000Source | 4,088,000Source | 6,072,000Source | 7,461,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 12,000,000Source | 32,500,000Source | 37,700,000Source | 42,800,000Source |
| Deferred Tax Liabilities, NetUSD | 3,283,000Source | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 6,078,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -23,360,000Source | 98,091,000Source | -112,662,000Source | -56,515,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 100,000Source | 100,000Source | 100,000Source | 100,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,188,000Source | 2,537,000Source | 3,641,000Source | 3,845,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 2,294,000Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | -6,318,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -24,495,000Source | -24,597,000Source | -33,772,000Source | -44,498,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 5,482,000Source | 4,500,000Source | -1,687,000Source | -2,402,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | 8,000Source | 11,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,488,000Source | 19,413,000Source | 28,669,000Source | 15,488,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -3,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -20,501,000Source | -684,000Source | -6,790,000Source | -31,412,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 33,229,000Source | 40,019,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | 5,000Source | 3,000Source | — |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 12,000,000Source | 32,500,000Source | 37,700,000Source | 42,800,000Source |
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | — | 0Source | 0Source | 0Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -6,000Source | -24,000Source | -28,000Source | -36,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | 10,000Source |
| General and Administrative ExpenseUSD | 12,213,000Source | 9,976,000Source | 11,915,000Source | 12,481,000Source |
| GoodwillUSD | 11,100,000Source | — | — | — |
| Goodwill, Impairment LossUSD | 0Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -23,360,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | -6,318,000Source | — | — | — |
| Investment Income, InterestUSD | 204,000Source | 9,000Source | 165,000Source | 1,150,000Source |
| Net Income (Loss) Attributable to ParentUSD | -23,360,000Source | 98,091,000Source | -112,662,000Source | -56,515,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -23,360,000Source | 96,941,000Source | -112,662,000Source | -84,558,000Source |
| Operating ExpensesUSD | 32,680,000Source | 27,673,000Source | 36,687,000Source | 47,515,000Source |
| Operating Lease, ExpenseUSD | 400,000Source | 300,000Source | 400,000Source | 300,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | 4,500,000Source | 10,499,000Source | 42,100,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 4,862,000Source | — | — | 1,448,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -27,818,000Source | -27,673,000Source | -36,687,000Source | -46,067,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -29,678,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | -6,318,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -23,360,000Source | 98,091,000Source | -112,662,000Source | -56,515,000Source |
| Earnings Per Share, BasicUSD per share | -7.18Source | 1.97Source | — | — |
| Earnings Per Share, DilutedUSD per share | -7.18Source | -0.58Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 3,255,648Source | 49,203,000Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 3,255,648Source | 50,127,000Source | — | — |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 15,000Source | 22,000Source | 61,000Source | 120,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -6,000Source | -24,000Source | -28,000Source | -36,000Source |
| General and Administrative ExpenseUSD | 12,213,000Source | 9,976,000Source | 11,915,000Source | 12,481,000Source |
| Goodwill, Impairment LossUSD | 0Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -23,360,000Source | — | — | — |
| Interest ExpenseUSD | — | 7,000Source | 3,000Source | — |
| Investment Income, InterestUSD | 204,000Source | 9,000Source | 165,000Source | 1,150,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -23,360,000Source | 96,941,000Source | -112,662,000Source | -84,558,000Source |
| Operating ExpensesUSD | 32,680,000Source | 27,673,000Source | 36,687,000Source | 47,515,000Source |
| Operating Lease, ExpenseUSD | 400,000Source | 300,000Source | 400,000Source | 300,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | 28,043,000Source |
| Research and Development ExpenseUSD | 12,188,000Source | 16,375,000Source | 24,772,000Source | 34,853,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 4,862,000Source | — | — | 1,448,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | — | 1,150,000Source | — | — |